News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–69
- Matches
- 69
- Sources here
- 15
- Companies here
- 2
Search results
Stored financial headlines
Active search
69 matching headlines
Ticker or company: IDYAMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
IDEAYA Biosciences Inc (IDYA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a brief overview of IDEAYA Biosciences Inc (IDYA)'s financial data, focusing on its revenue breakdown. It notes that detailed segment and regional revenue data has not yet been disclosed by the company. The available information indicates a reported revenue of $218.71M …
IDYA
main company
Sharemaestro market context
Trend signal active
52 weeks +44.5%
IDEAYA Biosciences Inc (IDYA) Financial Health: Profitability & Balance Sheet Analysis
This article provides a financial health analysis of IDEAYA Biosciences Inc (IDYA), indicating a current financial score of 5.99, ranking 302 out of 386 in its industry. The company's financial status is stable, but its operating efficiency is low, with several key financial metrics …
IDYA
main company
Sharemaestro market context
Trend signal active
52 weeks +44.5%
IDEAYA Biosciences Inc (IDYA) Valuation: PE, PB & Fair Value Analysis
The article provides a valuation analysis of IDEAYA Biosciences Inc (IDYA), noting its current valuation score of 8.91 and ranking within the Biotechnology & Medical Research industry. It details the company's current P/E ratio, highlighting its position relative to recent highs and lows. The …
IDYA
main company
Sharemaestro market context
Trend signal active
52 weeks +44.5%
IDEAYA Biosciences Inc (IDYA) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of IDEAYA Biosciences Inc (IDYA), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. As of July 24, 2026, the stock's price momentum score is 3.63, suggesting suitability for range-bound swing …
IDYA
main company
Sharemaestro market context
Trend signal active
52 weeks +44.5%
IDYA|IDEAYA Biosciences Inc|Price:35.380|Chg%:-0.850
This article provides a detailed financial overview of IDEAYA Biosciences Inc (IDYA), including its income statement, balance sheet, and cash flow statement. It highlights key financial indicators, earnings history, and analyst ratings, presenting data up to FY2026Q1 and addressing frequently asked questions about the …
IDYA
main company
Sharemaestro market context
Trend signal active
52 weeks +44.5%
ETFs Investing in IDEAYA Biosciences, Inc. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of IDEAYA Biosciences, Inc. (IDYA). It provides a detailed table of these funds, including their market value, weight of IDYA in their holdings, issuer, management style, focus, expense ratio, assets under management (AUM), …
IDYA
main company
Sharemaestro market context
Trend signal active
52 weeks +44.5%
IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs
IDEAYA Biosciences announced it will present three abstracts at the 2026 European Society of Medical Oncology (ESMO) meeting, showcasing updated data from its darovasertib clinical trials for uveal melanoma (OptimUM-02, OptimUM-01, OptimUM-09). Additionally, its partner Hengrui Pharma will present long-term results from the Phase …
IDYA
main company
Sharemaestro market context
Trend signal active
52 weeks +44.5%
How Ideaya Biosciences Inc. (IDYA) Affects Rotational Strategy Timing
Ideaya Biosciences Inc. (IDYA) shows a weak near-term sentiment but strong long-term potential, according to AI models. The analysis identifies a mid-channel oscillation pattern and offers three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles. These strategies include specific …
IDYA
main company
Sharemaestro market context
Trend signal active
52 weeks +44.5%
IDEAYA melanoma data and partner Hengrui's lung cancer results head to ESMO
IDEAYA Biosciences (NASDAQ: IDYA) announced that three darovasertib abstracts and one IDE849 abstract have been accepted for poster presentation at the ESMO 2026 Congress, to be held in Madrid, Spain. The presentations will cover updates from multiple uveal melanoma trials, including registrational and neoadjuvant …
IDYA
main company
Sharemaestro market context
Trend signal active
52 weeks +44.5%